Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratesWith |
gptkb:Eli_Lilly
|
| gptkbp:focusesOn |
oncology
biosimilars ophthalmology autoimmune diseases innovative biologic drugs |
| gptkbp:foundedIn |
2011
|
| gptkbp:founder |
gptkb:Michael_Yu
|
| gptkbp:headquartersLocation |
gptkb:Suzhou,_China
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Tyvyt_(sintilimab)
|
| gptkbp:numberOfEmployees |
over 4,000
|
| gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:01801.HK
|
| gptkbp:website |
https://www.innoventbio.com/
|
| gptkbp:bfsParent |
gptkb:Zhangjiang
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Innovent Biologics
|